Trademark: 88241679
Word
CABINET:
Status
Registered
Status Code
700
Status Date
Tuesday, July 4, 2023
Serial Number
88241679
Registration Number
7101112
Registration Date
Tuesday, July 4, 2023
Mark Type
4000
Filing Date
Wednesday, December 26, 2018
Published for Opposition
Tuesday, March 10, 2020

Trademark Owner History
Patel & Gong, Inc. - Original Registrant

Classifications
9 Downloadable software in the nature of a mobile application for use in connection with the collection, analysis, and sharing of personal medical data; Downloadable mobile applications for use in obtaining prescription and over the counter medications and referrals to healthcare providers; Downloadable mobile applications featuring pricing information for prescription drugs and over the counter medications, for purchasing of prescription drugs and over the counter medications, and for providing information regarding health, prescription drugs and over the counter medications
5 Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs; Analgesic and muscle relaxant pharmaceutical preparations
35 Retail pharmacy services; Retail store services for pharmaceutical and medical supplies
42 Providing online non-downloadable mobile applications for use in obtaining prescription and over the counter medications and referrals to healthcare providers

Trademark Events
Jul 4, 2023
Notice Of Registration Confirmation Emailed
Jul 4, 2023
Registered-Principal Register
May 27, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
May 26, 2023
Allowed Principal Register - Sou Accepted
May 11, 2023
Statement Of Use Processing Complete
May 5, 2023
Use Amendment Filed
May 5, 2023
Teas Statement Of Use Received
Nov 10, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 9, 2022
Sou Extension 5 Granted
Nov 7, 2022
Sou Extension 5 Filed
Nov 7, 2022
Teas Extension Received
Sep 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 31, 2022
Sou Extension 4 Granted
May 5, 2022
Sou Extension 4 Filed
Aug 30, 2022
Case Assigned To Intent To Use Paralegal
Aug 6, 2022
Notice Of Revival - E-Mailed
Aug 5, 2022
Extension Received With Teas Petition
Aug 5, 2022
Petition To Revive-Granted
Aug 5, 2022
Teas Petition To Revive Received
Jun 6, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 6, 2022
Abandonment - No Use Statement Filed
Nov 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2021
Sou Extension 3 Granted
Nov 5, 2021
Sou Extension 3 Filed
Nov 5, 2021
Teas Extension Received
May 7, 2021
Notice Of Approval Of Extension Request E-Mailed
May 5, 2021
Sou Extension 2 Granted
May 5, 2021
Sou Extension 2 Filed
May 5, 2021
Teas Extension Received
Nov 7, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 5, 2020
Sou Extension 1 Granted
Nov 5, 2020
Sou Extension 1 Filed
Nov 5, 2020
Teas Extension Received
May 5, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 10, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 10, 2020
Published For Opposition
Feb 19, 2020
Notification Of Notice Of Publication E-Mailed
Feb 4, 2020
Approved For Pub - Principal Register
Jan 23, 2020
Teas/Email Correspondence Entered
Jan 23, 2020
Correspondence Received In Law Office
Jan 23, 2020
Teas Request For Reconsideration Received
Nov 5, 2019
Notification Of Final Refusal Emailed
Nov 5, 2019
Final Refusal E-Mailed
Nov 5, 2019
Final Refusal Written
Oct 4, 2019
Teas/Email Correspondence Entered
Oct 1, 2019
Correspondence Received In Law Office
Oct 1, 2019
Teas Response To Office Action Received
Apr 1, 2019
Notification Of Non-Final Action E-Mailed
Apr 1, 2019
Non-Final Action E-Mailed
Apr 1, 2019
Non-Final Action Written
Apr 1, 2019
Removed From Teas Plus
Mar 19, 2019
Assigned To Examiner
Jan 17, 2019
New Application Office Supplied Data Entered
Dec 29, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24